Stay updated on Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry v3.6.6 was added to the history, replacing v3.6.5, reflecting an update to the page's release notes.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page history adds a new revision entry for v3.6.5, replacing the previous v3.6.4, indicating a page metadata update rather than a change to study records.SummaryDifference0.1%

- Check49 days agoChange DetectedA new Revision: v3.6.4 is now listed in the study record history, replacing the previous Revision: v3.6.3. This reflects a minor update to the page interface rather than changes to the study data.SummaryDifference0.1%

- Check70 days agoChange DetectedA new revision entry v3.6.3 has been added to the study's history, superseding the previous v3.6.2 entry.SummaryDifference0.1%

- Check77 days agoChange DetectedThe history section now shows a newer software revision (v3.6.2) replacing the older v3.6.0, indicating a background deployment that updates how history is displayed.SummaryDifference0.1%

- Check92 days agoChange DetectedThe record now shows the study is Completed and no longer looking for participants, with the Recruitment Status and Study Status sections updated accordingly to reflect the end of recruitment.SummaryDifference2%

Stay in the know with updates to Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.